肝脏 ›› 2023, Vol. 28 ›› Issue (12): 1410-1412.

• 肝功能衰竭 • 上一篇    下一篇

DPMAS联合LPE治疗中血浆吸附量影响因素分析

张秀秀, 胡彦明, 汤汝佳, 王开利, 姚红宇, 邢汉前, 刘鸿凌, 周霞   

  1. 100039 北京 解放军总医院第五医学中心肝病医学部血液净化中心
  • 收稿日期:2023-07-28 出版日期:2023-12-31 发布日期:2024-03-01
  • 通讯作者: 刘鸿凌, Email: lhl7125@sina.com;周霞,Email:zhouxia82121@163.com
  • 作者简介:共同第一作者:胡彦明
  • 基金资助:
    首都市民健康培育(Z161100000116058)

An analysis on the factors affecting adsorption capacity during dual plasma molecular adsorption combined with lower volume plasma exchange therapies

ZHANG Xiu-xiu, HU Yan-ming, TANG Ru-jia, WANG Kai-li, Yao Hong-yu, Xing Han-qian, LIU Hong-ling, ZHOU Xia   

  1. Department of Blood Purification, the 5th Medical Center of the PLA General Hospital, Beijing 100039, China
  • Received:2023-07-28 Online:2023-12-31 Published:2024-03-01
  • Contact: LIU Hong-ling, Email: lhl7125@sina.com;ZHOU Xia,Email:zhouxia82121@163.com

摘要: 目的 探讨双重血浆分子吸附(DPMAS)联合低量血浆置换(LPE)治疗中吸附量的情况影响因素。方法 2021年1月1日至2022年5月31日在解放军总医院第五医学中心进行DPMAS 联合LPE治疗的肝衰竭或高胆红素血症患者共161 例次。分析治疗过程中因各种原因引起吸附量减少(小于4000 mL)的常见情况、报警及其影响因素。结果 DPMAS 联合LPE治疗的161例次中,有24例次吸附量小于标准量,占14.9%。低吸附量组患者胆红素下降水平为(99.61±70.15)μmol/L,低于标准治疗组的(115.30±70.75)μmol/L,但差异无统计学意义(t=-0.964,P=0.337)。血管通路在两组间的差异较大(χ2=6.463,P=0.039),低吸附量组血流速度为(128.64±7.74)mL/min,低于标准组的(133.70±9.60)mL/min(t=-2.344,P=0.02)。低吸附量组发生不可纠正的仪器报警,主要为跨膜压(TMP)报警11例次(45.8%),静脉压(PV)报警8例次(33.3%)。低吸附组发生静脉壶加分离器凝血4例,单分离器凝血7例,静脉壶脂肪沉淀3例,低血压1例。结论 重症肝病患者使用DPMAS 联合LPE 治疗时,外周动静脉穿刺和低血流速更容易引起吸附的非计划中止,报警方式主要为跨膜压报警及静脉压报警,血液凝结和脂肪沉积是主要原因。

关键词: 双重血浆分子吸附, 血浆置换, 报警, 血管通路

Abstract: Objective To analyze the common factors affecting the adsorption capacity of patients with liver failure or severe hyperbilirubinemia during dual plasma molecular adsorption (DPMAS) and lower volume plasma exchange (LPE) treatment.Methods A total of 161 cases of liver failure or hyperbilirubinemia treated with DPMAS and LPE from January 1,2021 to May 31,2022 were collected. The common conditions, alarm and influencing factors of the adsorption reduction (less than 4000ml) caused by various reasons were analyzed.Results Of the 161 patients treated with DPMAS combined with LPE, 24 had the adsorption volume less than standard dose, accounting for 14.9% of the total treatment. The decrement of bilirubin level was lower than that in the standard treatment group, but there was no significant statistical difference (P=0.337). The vascular access varied greatly between the two groups (χ2=6.463, P=0.039), the proportion of peripheral arteriovenous imparements (AVIs) was higher in the low adsorption group than the standard group (62.5% vs 42.5%), and the flow velocity in the low adsorption group was lower than that in the standard group (t=-2.344, P=0.02). Among the 24 patients in the low adsorption group, all had uncorrected instrument alarm occurred, which included 11 transmembrane pressure (TMP) alarms (45.8%) and 8 venous pressure (VP) alarms (33.3%). In the low adsorption group, there were 4 cases of coagulation in vevous and multi-seperator, 7 cases of coagulation in single separator, 3 cases of fat deposition, and 1 case of hypotension.Conclusion When patients with severe liver disease are treated with DPMAS and LPE, peripheral arteripuncture and low blood flow rate are more likely to cause unplanned suspension of adsorption. The alarm mode is mainly transmembrane pressure alarm and venous pressure alarm, with blood clot and fat deposition as the main reasons.

Key words: Dual plasma molecular adsorption, Plasma exchange, Alarm, Vascular access